The "U.S. Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report by Stage Type (Preclinical, Clinical, Commercial), Customer Type, Therapeutic Area, Region, and Segment ...
This month, the Joe Biden administration awarded $14 million to the API Innovation Center, a Saint Louis–based nonprofit that aims to remedy supply chain problems for active pharmaceutical ingredients ...
Small molecule drugs dominate new drug approvals and are crucial for treating diverse diseases. They are typically low-weight, providing easy absorption and versatile delivery methods. Their simpler ...
Small Molecule CMO/CDMO Market Report On Size, Share, Competitive Landscape, And Trends Analysis. EINPresswire/ -- The small molecule CMO/CDMO sector is experiencing robust growth fueled by evolving ...
A version of this story appeared in Volume 101, Issue 36 Not too long ago, these small-molecule drugs looked as if they were going out of fashion. Advances in biotechnology enabled pharmaceutical ...
TEL AVIV, Israel--(BUSINESS WIRE)--Teva announced today its intention to divest its active-pharmaceutical ingredient (API) business, or "TAPI". TAPI is a global leader in the small-molecule API ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback